about
ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cellsInterferon regulatory factor 8-deficiency determines massive neutrophil recruitment but T cell defect in fast growing granulomas during tuberculosisIL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activationCyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosisICSBP/IRF-8 differentially regulates antigen uptake during dendritic-cell development and affects antigen presentation to CD4+ T cellsThe dangerous liaison between pollens and pollution in respiratory allergy.Cancer-driven dynamics of immune cells in a microfluidic environment.IRF-8 controls melanoma progression by regulating the cross talk between cancer and immune cells within the tumor microenvironment.Chemo-immunotherapy induces tumor regression in a mouse model of spontaneous mammary carcinogenesis.STAT1 regulates IFN-alpha beta- and IFN-gamma-dependent control of infection with Chlamydia pneumoniae by nonhemopoietic cells.The tumor microenvironment: a pitch for multiple players.Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer.Type I Interferons as Stimulators of DC-Mediated Cross-Priming: Impact on Anti-Tumor Response.Combining Type I Interferons and 5-Aza-2'-Deoxycitidine to Improve Anti-Tumor Response against Melanoma.Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils.Mycobacterium tuberculosis PstS1 amplifies IFN-γ and induces IL-17/IL-22 responses by unrelated memory CD4+ T cells via dendritic cell activation.Organs on chip approach: a tool to evaluate cancer -immune cells interactions.TIM-3 as a molecular switch for tumor escape from innate immunity.The dual role of IRF8 in cancer immunosurveillance.IRF-1 deficiency skews the differentiation of dendritic cells toward plasmacytoid and tolerogenic features.Cross talk between cancer and immune cells: exploring complex dynamics in a microfluidic environment.Novel allergic asthma model demonstrates ST2-dependent dendritic cell targeting by cypress pollen.Cyclophosphamide induces type I interferon and augments the number of CD44(hi) T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer.Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.Type I IFN regulate DC turnover in vivo.Type I IFNs control antigen retention and survival of CD8α(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming.Eosinophils: The unsung heroes in cancer?A multidisciplinary study using in vivo tumor models and microfluidic cell-on-chip approach to explore the cross-talk between cancer and immune cells.Type I interferons produced by dendritic cells promote their phenotypic and functional activationDisruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem CellsCorrection: Interferon Regulatory Factor 8-Deficiency Determines Massive Neutrophil Recruitment but T Cell Defect in Fast Growing Granulomas during TuberculosisICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cellsFrom Petri Dishes to Organ on Chip Platform: The Increasing Importance of Machine Learning and Image AnalysisBasophils in Tumor Microenvironment and SurroundingsIL-33 Promotes CD11b/CD18-Mediated Adhesion of Eosinophils to Cancer Cells and Synapse-Polarized Degranulation Leading to Tumor Cell KillingTumor-Intrinsic or Drug-Induced Immunogenicity Dictates the Therapeutic Success of the PD1/PDL Axis BlockadeMulticentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring
P50
Q24672345-638C6A24-CB14-4FE4-BA57-5CAAAAB32568Q27321749-A42C2F7E-A603-4021-8A94-1AF641A326B2Q28207915-1168C2C3-4DC7-45C6-A18F-DEB6D8BE1F13Q28300987-E05A9734-E01E-433A-9F41-C18E3E929C79Q28304270-D247130F-C558-49D7-909D-A2F448E4E3A1Q30238690-4414A6DD-ED92-4360-8A4C-888F330822CDQ30843720-742CB79B-15E9-42CD-999E-4F98C078C795Q36520732-03DA9C47-BDD2-44BB-8EE6-661F7AEA4D48Q37644937-0885DB62-4834-4444-9226-A7444B782CC9Q37862244-B89C446C-8C05-4B72-A327-A74015D5FFEBQ38101567-4CD2577F-B1B8-441F-8025-9A95520D7E91Q38115968-E8DE16E1-4889-47B1-A8C4-01675D344576Q38176613-0F902FF3-FCE2-4937-8931-67DD650D5FC3Q38746537-9AC7F7D4-3359-408A-9141-0C11625DAD4EQ38823705-05F3C96B-FA85-4494-87AB-5880E00DAFF0Q40146282-FE99D66E-3D1D-4D83-89F3-0B3F2DAA4202Q42261100-D5EABFDC-20C0-4EB8-8FCE-97F8291AA4E7Q42371821-E48DF555-9838-491F-BDC4-0AC5EA9B2CE7Q42583763-AA3A1CD5-C470-4A24-894E-60EADB87BC82Q42931800-D2451018-D29A-4867-B677-A057D150E76EQ43871949-E4B92B8A-A8A3-45DF-A0AD-F3EE77DCB13AQ43916547-065E19A4-DCC5-4A70-B756-A148942870C5Q44266813-2E7290B1-BE51-4228-803F-022C8FEB456FQ44527902-8B13877A-7CCA-447A-A31D-23F9BA3C0A3DQ44550766-1C475D75-978F-40D6-80AE-E18DC14B184BQ44680243-B72669B2-8F84-447A-8A91-9AA7DB7589C7Q45397464-622161E8-1095-44BE-A2E9-82F488FDFA80Q47225787-FAA192D3-9881-4615-8F37-F99382EA51C9Q51520620-5299C8D6-1E39-4F74-AD97-C6E847EACE22Q61473768-D4220E07-96F6-4580-8FAA-F8202890440DQ62623090-07C6C69D-C81F-4675-B490-53BA32A54AF4Q63309849-372C7802-BBB9-4956-BA53-6D31F96E7B54Q63309966-3BD2E363-67CE-41F6-AD86-08729D5E369DQ64100767-0C78903C-5544-4677-886F-BECCD97F0277Q89613146-D833ED87-9E6E-454B-869A-DDDEC1F645A9Q91254181-9340F2AA-80A9-4F86-9B3D-F0BF49815876Q91922734-9C5438DD-57C4-4B68-9619-6F8A01C4FCA8Q93167058-C74B8D35-BCF8-4D4A-B729-9B7074681D44
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Giovanna Schiavoni
@ast
Giovanna Schiavoni
@en
Giovanna Schiavoni
@es
Giovanna Schiavoni
@nl
Giovanna Schiavoni
@sl
type
label
Giovanna Schiavoni
@ast
Giovanna Schiavoni
@en
Giovanna Schiavoni
@es
Giovanna Schiavoni
@nl
Giovanna Schiavoni
@sl
prefLabel
Giovanna Schiavoni
@ast
Giovanna Schiavoni
@en
Giovanna Schiavoni
@es
Giovanna Schiavoni
@nl
Giovanna Schiavoni
@sl
P1053
T-4418-2017
P106
P1153
7004538111
P21
P2798
P31
P3829
P496
0000-0001-9135-0556